
Rice University bioengineers use a magnetic field to activate nanoparticle-attached baculoviruses in a tissue. The viruses, which normally infect alfalfa looper moths, are modified to deliver gene-editing DNA code only to cells that are targeted with magnetic field-induced local transduction. Courtesy of the Laboratory of Biomolecular Engineering and Nanomedicine
Experimental Rice U. therapy could repair mutations that cause genetic diseases
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container drawn from a particular species of moth to deliver CRISPR/Cas9 payloads that modify genes in a specific tissue or organ with spatial control.
Because magnetic fields are simple to manipulate and, unlike light, pass easily through tissue, Bao and his colleagues want to use them to control the expression of viral payloads in target tissues by activating the virus that is otherwise inactivated in blood.
The research appears in Nature Biomedical Engineering.
In nature, CRISPR/Cas9 bolsters microbes’ immune systems by recording the DNA of invaders. That gives microbes the ability to recognize and attack returning invaders, but scientists have been racing to adapt CRISPR/Cas9 to repair mutations that cause genetic diseases and to manipulate DNA in laboratory experiments.
CRISPR/Cas9 has the potential to halt hereditary disease – if scientists can get the genome-editing machinery to the right cells inside the body. But roadblocks remain, especially in delivering the gene-editing payloads with high efficiency.
Bao said it will be necessary to edit cells in the body to treat many diseases. “But efficiently delivering genome-editing machinery into target tissue in the body with spatial control remains a major challenge,” Bao said. “Even if you inject the viral vector locally, it can leak to other tissues and organs, and that could be dangerous.”
The delivery vehicle developed by Bao’s group is based on a virus that infects Autographa californica, aka the alfalfa looper, a moth native to North America. The cylindrical baculovirus vector (BV), the payload-carrying part of the virus, is considered large at up to 60 nanometers in diameter and 200-300 nanometers in length. That’s big enough to transport more than 38,000 base pairs of DNA, which is enough to supply multiple gene-editing units to a target cell, Bao said.
He said the inspiration to combine BV and magnetic nanoparticles came from discussions with Rice postdoctoral researcher and co-lead author Haibao Zhu, who learned about the virus during a postdoctoral stint in Singapore but knew nothing about magnetic nanoparticles until he joined the Bao lab. The Rice team had previous experience using iron oxide nanoparticles and an applied magnetic field to open blood vessel walls just enough to let large-molecule drugs pass through.
“We really didn’t know if this would work for gene editing or not, but we thought, ‘worth a shot,’” Bao said.
The researchers use the magnetic nanoparticles to activate BV and deliver gene-editing payloads only where they’re needed. To do this, they take advantage of an immune-system protein called C3 that normally inactivates baculoviruses.
“If we combine BV with magnetic nanoparticles, we can overcome this deactivation by applying the magnetic field,” Bao said. “The beauty is that when we deliver it, gene editing occurs only at the tissue, or the part of the tissue, where we apply the magnetic field.”
Application of the magnetic field allows BV transduction, the payload-delivery process that introduces gene-editing cargo into the target cell. The payload is also DNA, which encodes both a reporter gene and the CRISPR/Cas9 system.
In tests, the BV was loaded with green fluorescent proteins or firefly luciferase. Cells with the protein glowed brightly under a microscope, and experiments showed the magnets were highly effective at targeted delivery of BV cargoes in both cell cultures and lab animals.
Bao noted his and other labs are working on the delivery of CRISPR/Cas9 with adeno-associated viruses (AAV), but he said BV’s capacity for therapeutic cargo is roughly eight times larger. “However, it is necessary to make BV transductioninto target cells more efficient,” he said.
Learn more: Moths and magnets could save lives
The Latest on: Genetic diseases
[google_news title=”” keyword=”genetic diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Genetic diseases
- Op/Ed: We're sisters, Purdue students and rare disease patient advocates. Here's our storyon March 29, 2023 at 2:09 am
I, Amelia, am 22 years old and have been diagnosed with three different rare diseases stemming from a genetic mutation affecting my collagen. It took me several years after the onset of my symptoms to ...
- Pre-Implantation Genetic Diagnosis (PGD) Market by 2031on March 29, 2023 at 1:53 am
Growing demand for [Stem Cell Therapy, , IVF Prognosis, , Late-Onset Genetic Disorders, , Inherited Genetic Disease, , Others, ] around the world has had a direct impact on the growth of the ...
- Understanding Wilson’s disease, a Rare Genetic Disorderon March 28, 2023 at 8:34 pm
Wilson’s disease is a lifelong condition, but early diagnosis and treatment can significantly improve the patient’s quality of life. It is a genetic disorder and both parents must carry the defective ...
- Aslanidi publishes research that could lead to new treatments for genetic diseaseson March 28, 2023 at 7:19 pm
The Hormel Institute, University of Minnesota's, George Aslanidi, PhD, has published research that could lead to improved access to personalized treatment for patients with genetic diseases. With more ...
- How do viral infections cause autoimmune diseases?on March 28, 2023 at 5:39 pm
Study: The Role of Viral Infections in the Onset of Autoimmune Diseases. Image Credit: successfulalexey78 / Shutterstock.com. What are AIDs? Several decades of research have been ...
- Alabama screening newborns for two additional genetic disorderson March 27, 2023 at 4:13 pm
The Alabama Department of Public Health is now screening newborns for two additional genetic disorders: X-ALD and ADA-SCID.
- Is your pet at risk? 5 genetic disorders every pet owner should know abouton March 27, 2023 at 5:16 am
Genetic disorders in pets can be a source of concern for pet owners as they can affect the health and well-being of their furry companions. Here are some of the most common genetic disorders in pets.
- Insights into causes of rare genetic immune disorderson March 27, 2023 at 4:32 am
The APDS disorders are similar in their impacts but follow different genetic pathways. Variations in the PIK3R1 gene underlie APDS2, while variations in PIK3CD underlie APDS1. Though both result ...
- Genetic tests unexpectedly find genes linked to heart disease - now what?on March 27, 2023 at 2:00 am
As health care professionals, researchers and consumers increasingly use genetic testing, they are uncovering incidental genetic abnormalities, or variants, that are associated with cardiovascular ...
via Bing News